Serum anti-endothelial cell antibodies in patients with age-related macular degeneration treated with intravitreal bevacizumab.
第一单位:
Department of Ophthalmology and Ocular Oncology, Jagiellonian University Medical College, Krakow, Malopolska, Poland. akubicka@onet.pl.
作者:
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);血管生成抑制剂(Angiogenesis Inhibitors);动物(Animals);自身抗体(Autoantibodies);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);女(雌)性(Female);荧光抗体技术, 间接(Fluorescent Antibody Technique, Indirect);人类(Humans);玻璃体内注射(Intravitreal Injections);猕猴属(Macaca);男(雄)性(Male);中年人(Middle Aged);肌, 骨骼(Muscle, Skeletal);血管内皮生长因子A(Vascular Endothelial Growth Factor A);视敏度(Visual Acuity);湿性黄斑变性(Wet Macular Degeneration)
DOI
10.1111/aos.13033
PMID
27329255
发布时间
2017-01-25
- 浏览22

Acta ophthalmologica
e617-e623页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文